Quantitative proteomics for identifying biomarkers for tuberculous meningitis

Clinical Proteomics

Volumn 9, Issue 1, 2012, Pages

  Kumar, Ghantasala S Sameer ^a,b   Venugopal, Abhilash K ^a,b,c,d   Mahadevan, Anita ^e   Renuse, Santosh ^a,c,d,f   Harsha, H C ^a   Sahasrabuddhe, Nandini A ^a,g   Pawar, Harsh ^a,h   Sharma, Rakesh ^e   Kumar, Praveen ^a   Rajagopalan, Sudha ⁱ   Waddell, Keith ^j   Ramachandra, Yarappa L ^b   Satishchandra, Parthasarathy ^e   Chaerkady, Raghothama ^a,b,c,d   Prasad, T S Keshava ^a,f,g,k   Shankar, K ^e   Pandey, Akhilesh ^a,c,d  

^a INSTITUTE OF BIOINFORMATICS   (India)

^b KUVEMPU UNIVERSITY   (India)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^f AMRITA UNIVERSITY   (India)

^g MANIPAL UNIVERSITY   (India)

^h RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES   (India)

ⁱ Shell Technology India Pvt Ltd   (India)

^j AGILENT TECHNOLOGIES   (United States)

^k PONDICHERRY UNIVERSITY   (India)

more..

Author keywords

Cerebrospinal fluid; Early diagnosis; Histopathology; Relative quantitation; Tuberculosis

Indexed keywords

AMPHIPHYSIN; CELL ADHESION MOLECULE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFASCIN; PEROXIREDOXIN 5; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE FAMILY MEMBER 6; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; UNCLASSIFIED DRUG; VIMENTIN;

ACCURACY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TUBERCULOUS MENINGITIS; UPREGULATION; VALIDITY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84879606270     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-9-12     Document Type: Article

References (57)

1. World Health Organization, Geneva, Switzerland: The International Journal of Tuberculosis and Lung Disease 2006, 10:1091-1097.
2. Fanning A: Tuberculosis: 6. Extrapulmonary disease. CMAJ 1999, 160:1597-1603. (Pubitemid 29265372)
3. Garg RK: Tuberculosis of the central nervous system. Postgrad Med J 1999, 75(881):133-40. (Pubitemid 29097462)
4. Hosoglu S, Geyik MF, Balik I, et al: Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2002, 6(1):64-70. (Pubitemid 34263547)
5. Thwaites GE, Nguyen DB, Nguyen HD, et al: Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004, 351(17):1741-51.
6. Berenguer J, Moreno S, Laguna F, et al: Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992, 326(10):668-72.
7. Azuaje C, Fernandez Hidalgo N, Almirante B, et al: Tuberculous meningitis: A comparative study in relation to concurrent human immunodeficiency virus infection. Enferm Infecc Microbiol Clin 2006, 24(4):245-250. (Pubitemid 43874421)
8. Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J: Tuberculous meningitis. J Neurol Neurosurg Psychiatry 2000, 68(3):289-99. (Pubitemid 30248701)
9. Dinnes J, Deeks J, Kunst H, et al: A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007, 11(3):1-196.
10. Eintracht S, Silber E, Sonnenberg P, Koornhof HJ, Saffer D: Analysis of adenosine deaminase isoenzyme-2 (ADA(2)) in cerebrospinal fluid in the diagnosis of tuberculosis meningitis. J Neurol Neurosurg Psychiatry 2000, 69(1):137-8. (Pubitemid 30410437)
11. Donald PR, Malan C, van der Walt A, Schoeman JF: The simultaneous determination of cerebrospinal fluid and plasma adenosine deaminase activity as a diagnostic aid in tuberculous meningitis. S Afr Med J 1986, 69(8):505-7. (Pubitemid 16069899)
12. Mishra OP, Loiwal V, Ali Z, Nath G, Chandra L: Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in children. J Trop Pediatr 1996, 42(3):129-32. (Pubitemid 26174518)
13. Kashyap RS, Kainthla RP, Mudaliar AV, Purohit HJ, Taori GM, Daginawala HF: Cerebrospinal fluid adenosine deaminase activity: A complimentary tool in the early diagnosis of tuberculous meningitis. Cerebrospinal Fluid Res. 2006, 3:5.
14. Nishida Y, Komachi H, Mizusawa H: A case of Listeria meningitis associated with increased adenosine deaminase in cerebrospinal fluid. Diagn Microbiol Infect Dis 2007, 57(4):435-7. (Pubitemid 46498646)
15. Mudaliar AV, Kashyap RS, Purohit HJ, Taori GM, Daginawala HF: Detection of 65 kD heat shock protein in cerebrospinal fluid of tuberculous meningitis patients. BMC Neurol 2006, 6:34.
16. Donald PR, Malan C: Cerebrospinal fluid lactate and lactate dehydrogenase levels as diagnostic aids in tuberculous meningitis. S Afr Med J 1985, 67(1):19-20. (Pubitemid 15162298)
17. Molavi A, LeFrock JL: Tuberculous meningitis. Med Clin North Am 1985, 69(2):315-31. (Pubitemid 15042676)
18. Wilder-Smith A, Wilder-Smith E: Tuberculous meningitis and corticosteroids: A review. Neurol J Southeast Asia 1998, 3:57-60.
19. Lorber J: The results of treatment of 549 cases of tuberculous meningitis. Am Rev Tuberc 1954, 69(1):13-25.
20. Verdon R, Chevret S, Laissy JP, Wolff M: Tuberculous meningitis in adults: Review of 48 cases. Clin Infect Dis 1996, 22(6):982-8. (Pubitemid 26260599)
21. Chaerkady R, Pandey A: Applications of proteomics to lab diagnosis. Annu Rev Pathol 2008, 3:485-98. (Pubitemid 351488290)
22. Han X, Aslanian A, Yates JR 3rd: Mass spectrometry for proteomics. Curr Opin Chem Biol 2008, 12(5):483-90.
23. Ackermann BL, Hale JE, Duffin KL: The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab 2006, 7(5):525-39.
24. Chaerkady R, Pandey A: Quantitative proteomics for identification of cancer biomarkers. Proteomics Clin Appl 2007, 1(9):1080-9.
25. Shiio Y, Aebersold R: Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry. Nat Protoc 2006, 1(1):139-45.
26. Chaerkady R, Harsha HC, Nalli A, et al: A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res 2008, 7(10):4289-98.
27. Choe L, D'Ascenzo M, Relkin NR, et al: 8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease. Proteomics 2007, 7(20):3651-60. (Pubitemid 350022271)
28. Martin B, Brenneman R, Becker KG, Gucek M, Cole RN, Maudsley S: iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: Understanding the interface between physiology and disease. PLoS One 2008, 3(7):e2750.
29. Pawar H, Kashyap MK, Sahasrabuddhe NA, et al: Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther 2011, 12(6):510-22.
30. Prasad TSK, Keerthikumar S, et al: Comparative proteomic analysis of Candida albicans and Candida glabrata. Clinical Proteomics 2010, 6:163-173.
31. Ross PL, Huang YN, Marchese JN, et al: Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004, 3(12):1154-69.
32. Venugopal A, Chaerkady R, Pandey A: Application of mass spectrometrybased proteomics for biomarker discovery in neurological disorders. Ann Indian Acad Neurol. 2009, 12(1):3-11.
33. Yang W, Woltjer RL, Sokal I, et al: Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonismdementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. Am J Pathol 2007, 171(3):993-1002. (Pubitemid 47440996)
34. Zieske LR: A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 2006, 57(7):1501-8.
35. Goel R, Muthusamy B, Pandey A, Prasad TS: Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology. Mol Biotechnol 2011, 48(1):87-95.
36. Garg A, Barnes PF, Porgador A, et al: Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J Immunol 2006, 177(9):6192-8. (Pubitemid 44628837)
37. Thuong NT, Dunstan SJ, Chau TT, et al: Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog 2008, 4(12):e1000229.
38. Beisiegel M, Mollenkopf HJ, Hahnke K, et al: Combination of host susceptibility and Mycobacterium tuberculosis virulence define gene expression profile in the host. Eur J Immunol 2009, 39(12):3369-84.
39. Kumar GSS, Venugopal AK, Selvan LDN, Marimuthu A, Keerthikumar S, Pathare S, Dikshit JB, Tata P, Hariharan R, Prasad TSK, Harsha HC, Ramachandra YL, Mahadevan A, Chaerkady R, Shankar SK, Pandey A: Gene expression profiling of tuberculous meningitis. J Proteomics Bioinformatics 2011, 4(5):98-105.
40. Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM: Inhibition of EGFRmediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs). Oncogene 2000, 19(35):3999-4010.
41. Stofega MR, Argetsinger LS, Wang H, Ullrich A, Carter-Su C: Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha. J Biol Chem 2000, 275(36):28222-9.
42. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A: A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997, 386(6621):181-6. (Pubitemid 27131446)
43. Neznanov N, Neznanova L, Kondratov RV, O'Rourke DM, Ullrich A, Gudkov AV: The ability of protein tyrosine phosphatase SHP-1 to suppress NFkappaB can be inhibited by dominant negative mutant of SIRPalpha. DNA Cell Biol 2004, 23(3):175-82. (Pubitemid 38373084)
44. Neznanov N, Neznanova L, Kondratov RV, et al: Dominant negative form of signal-regulatory protein-alpha (SIRPalpha/SHPS-1) inhibits tumor necrosis factor-mediated apoptosis by activation of NF-kappa B. J Biol Chem 2003, 278(6):3809-15. (Pubitemid 36801108)
45. Hayano T, Kikuchi M: Cloning and sequencing of the cDNA encoding human P5. Gene 1995, 164(2):377-8.
46. Berwin B, Floor E, Martin TF: CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis. Neuron 1998, 21(1):137-45. (Pubitemid 28355698)
47. Renden R, Berwin B, Davis W, et al: Drosophila CAPS is an essential gene that regulates dense-core vesicle release and synaptic vesicle fusion. Neuron 2001, 31(3):421-37. (Pubitemid 32778561)
48. Wigge P, Kohler K, Vallis Y, et al: Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell 1997, 8(10):2003-15. (Pubitemid 27451117)
49. Vozzolo L, Loh B, Gane PJ, et al: Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. J Biol Chem 2010, 285(50):39314-28.
50. Zonta B, Tait S, Melrose S, et al: Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system. J Cell Biol 2008, 181(7):1169-77. (Pubitemid 351915490)
51. Zonta B, Desmazieres A, Rinaldi A, et al: A critical role for Neurofascin in regulating action potential initiation through maintenance of the axon initial segment. Neuron 2011, 69(5):945-56.
52. Koticha D, Babiarz J, Kane-Goldsmith N, Jacob J, Raju K, Grumet M: Cell adhesion and neurite outgrowth are promoted by neurofascin NF155 and inhibited by NF186. Mol Cell Neurosci 2005, 30(1):137-48. (Pubitemid 41133347)
53. Friedman A, Arosio P, Finazzi D, Koziorowski D, Galazka-Friedman J: Ferritin as an important player in neurodegeneration. Parkinsonism Relat Disord 2011, (6):423-430.
54. Maresca V, Flori E, Cardinali G, et al: Ferritin light chain down-modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation. J Cell Physiol 2006, 206(3):843-8. (Pubitemid 43191060)
55. Roeser H, Jacobs A, Worwood M: In Iron metabolism in biochemistry and medicine. Volume 2. Edited by Jacobs A, Worwood M.; 1980:605-640.
56. Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM: J Biol Chem 1995, 270:15285-15293.
57. Kandasamy K, Keerthikumar S, Goel R, et al: Human Proteinpedia: A unified discovery resource for proteomics research. Nucleic Acids Res 2009, 37 773-781.